Actionable news
All posts from Actionable news

Prospectuses and communications, business combinations


The following is a letter being provided to TriVasculars suppliers

We are pleased to announce that Endologix ® and TriVascular ® have agreed to a merger and expect to become a single company focused on aortic disorders in the first quarter of 2016. Until the deal closes however, we will remain separate companies. Endologix and TriVascular will continue to manage their supplier relationships independently until the merger formally closes.

From the beginning, our Mission has been to make EVAR better, safer, less invasive and available to more patients. We believe the combined companies will be uniquely positioned to offer vascular specialists a comprehensive range of AAA devices along with the service capability needed to accelerate the pursuit of our important mission.

This merger will combine two innovation leaders sharply focused on improving endovascular solutions to treat aortic disease. It will also bring together three unique and complementary technologies AFX ® , Ovation ® , and Nellix ® 1 platforms that represent the broadest product offering and indications in AAA. The quality and breadth of these solutions will enable clinicians to optimize AAA treatment to the individual requirements of each patient. In addition to a comprehensive range of innovative aortic devices, the merger will enable the combined entity to expand our sales and clinical team.

Together, Endologix and TriVascular have a deep pipeline of new technologies and we remain committed to our business model of physician-driven innovation. Through our ongoing partnership with clinicians, we will continue to develop, manufacture and market revolutionary solutions to further advance endovascular treatment of aortic disease. This does not happen without the important collaborative relationships both TriVascular and Endologix enjoy with their respective suppliers of goods and services.

Following the close of the merger, efforts to engage with the combined supply base will be initiated to align the collective efforts of our suppliers with the new combined entity. Until then, we will continue to operate as independent companies. Please contact me or your TriVascular Supply Chain contact if you have any questions about the merger. We...